20
Bcn Peptides Sa, based in Spain, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is TETRACOSACTIDE, with a corresponding US DMF Number 18963.
Remarkably, this DMF maintains an Active status since its submission on November 18, 2005, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 31, 2013, and payment made on January 11, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II